LDL Particle Number (LDL-P)
LDL-P directly quantifies the number of circulating low-density lipoprotein particles using nuclear magnetic resonance spectroscopy, resolving discordance between LDL cholesterol mass and particle count.
Standard vs. Optimal Reference Rangesnmol/L
Standard reference intervals represent the statistical 95% distribution of unselected commercial populations. Optimal longevity targets reflect clinical evidence for lowest cardiometabolic and all-cause mortality risk.
Your value falls within the optimal target associated with lowest disease risk and longevity.
< 1000 nmol/L
General reference distribution across unselected commercial populations.
< 700 nmol/L
Concentration target associated with minimal all-cause cardiometabolic mortality.
Molecular Mechanism & Clinical Purpose
In metabolic syndrome and insulin resistance, LDL particles become cholesterol-depleted and enriched in triglycerides. A patient may present with normal LDL-C (100 mg/dL) but dangerous particle overproduction (LDL-P > 1600 nmol/L), driving atherogenesis.
Differential Diagnosis
Elevated Levels (LDL-P High)
- •Insulin resistance and hypertriglyceridemia
- •Familial hypercholesterolemia
- •Metabolic syndrome
Low Levels (LDL-P Low)
- •Low atherogenic risk phenotype
- •High-intensity statin / ezetimibe / PCSK9i therapy
Technical Reference & Deep Dive
Biochemistry & Enzymatic Pathways
Longevity Risk Architecture & Epidemiology
Pre-Analytical Caveats & Diagnostic Workup
Pre-Analytical Considerations:
Standard testing requires a 10 to 12 hour overnight fast to minimize postprandial chylomicron interference, although LDL-P direct immunoassay is less sensitive to prandial state than calculated LDL-C. Avoid strenuous high-intensity exercise 24 hours prior to blood draw. Serum separator tubes (SST) or EDTA plasma should be centrifuged within 2 hours. High-dose biotin (>5 mg/day) supplementation may interfere with competitive streptavidin-biotin immunoassays, requiring a 48-hour washout period.
Reflexive Testing Protocol:
- Advanced Lipoprotein Particle Quantification (NMR spectroscopy or ion mobility LDL-P)
- Lipoprotein(a) [Lp(a)] baseline evaluation for genetic cardiovascular risk stratification
- Coronary Artery Calcium (CAC) score via non-contrast cardiac CT to evaluate calcified plaque burden
- High-sensitivity C-Reactive Protein (hs-CRP) to assess systemic vascular inflammatory tone
- Carotid intima-media thickness (CIMT) duplex ultrasound to assess subclinical atherosclerosis
Clinical Citations & Primary Literature (1)
- [1]Discordance Between LDL-C and LDL-P in Primary Prevention - Journal of Clinical Lipidology (2021). PMID: 33612401
Associated Longevity Guides & Clinical Calculators
Medicine 3.0Explore comprehensive evidence-based clinical protocols, testing costs, and algorithmic calculators that incorporate LDL Particle Number (LDL-P) into overall healthspan optimization.